Shan Xu

Rational design and synthesis of 2,4-dichloro-6-methyl pyrimidine derivatives as potential selective EGFRT790M/L858R inhibitors for the treatment of non-small cell lung cancer.

Y. Tu, Caolin Wang, Qingshan Pan, 2024, Archiv der Pharmazie.

Pyrrole-containing hybrids as potential anticancer agents: An insight into current developments and structure-activity relationships.

Wufu Zhu, Zhihui Zhou, Han Zhang, 2024, European journal of medicinal chemistry.

Space-confined nanozyme with cascade reaction based on PCN-224 for synergistic bacterial infection treatment and NIR fluorescence imaging of wound bacterial infections

Linxiao Wang, Wufu Zhu, Qingshan Pan, 2024, Chemical Engineering Journal.

Light-responsive Au@Zn-TCPP nanozyme functionalized with cell-penetrating peptide and antisense oligonucleotide for sensing living bacteria and synergistic therapy of diabetic wounds

Wufu Zhu, Qingshan Pan, Yijun Liu, 2024, Chemical Engineering Journal.

Coordination-Driven Self-Assembly of Metal Ion-Antisense Oligonucleotide Nanohybrids for Chronic Bacterial Infection Therapy.

Wufu Zhu, Qingshan Pan, Rujue Peng, 2024, ACS applied materials & interfaces.

Novel bioactive 2‐phenyl‐4‐aminopyrimidine derivatives as EGFRDel19/T790M/C797S inhibitors for the treatment of non‐small cell lung cancer

Wufu Zhu, Zhihui Zhou, Jie He, 2023, Archiv der Pharmazie.

T5S1607 identified as a antibacterial FtsZ inhibitor：Virtual screening combined with bioactivity evaluation for the drug discovery

Linxiao Wang, Qidong Tang, Wufu Zhu, 2023, Comput. Biol. Chem..

A patent review of small molecule CDK4/6 inhibitors in the treatment of cancer: 2020-present.

Wufu Zhu, Shidi Xu, Lei Duan, 2024, Expert opinion on therapeutic patents.